| budesonide/formoterol / Generic mfg. |
NCT01141465: Real-world Effectiveness of Combination Therapy in Asthma |
|
|
| Completed | N/A | 815377 | Europe | Fluticasone / formoterol metered dose inhaler, Seretide MDI, Fluticasone / salmeterol dry powder inhaler, Seretide DPI, Budesonide / formoterol dry powder inhaler, Symbicort DPI, Fluticasone / salmeterol metred dose inhaler, BUD/FOR dry powder inhaler | Research in Real-Life Ltd, Mundipharma Research Limited | Asthma | 06/07 | 02/10 | | |
NCT00524641: Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler |
|
|
| Completed | N/A | 1254 | RoW | | AstraZeneca | Asthma | 03/08 | 04/08 | | |
NCT00573222: Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma |
|
|
| Completed | N/A | 330 | RoW | Symbicort | AstraZeneca | Asthma | 05/08 | 05/08 | | |
NCT00782314: Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice |
|
|
| Completed | N/A | 400 | Europe | | AstraZeneca | Asthma | | 04/09 | | |
NCT00785733: NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART |
|
|
| Completed | N/A | 1182 | Europe | | AstraZeneca | Moderate/Severe Asthma | 10/09 | 10/09 | | |
NCT00503061: A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART |
|
|
| Completed | N/A | 1000 | Europe | | AstraZeneca | Bronchial Asthma | 05/10 | 05/10 | | |
NCT01218399: Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations |
|
|
| Completed | N/A | 10 | US | Symbicort, Budesonide | Stanford University, AstraZeneca | Asthma | 07/10 | 07/10 | | |
NCT00937066: Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART) |
|
|
| Completed | N/A | 1000 | RoW | | AstraZeneca | Asthma | | | | |
SYMBIOSE, NCT00812357: Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France |
|
|
| Completed | N/A | 579 | Europe | | AstraZeneca | Asthma | 03/11 | 08/11 | | |
NCT00784953: Real Life Effectiveness in Patients With Not Optimally Controlled Asthma |
|
|
| Completed | N/A | 842 | RoW | | AstraZeneca | Asthma | 05/11 | 05/11 | | |
| Completed | N/A | 3643 | Japan | | AstraZeneca | Bronchial Asthma | 10/11 | 10/11 | | |
| Completed | N/A | 1500 | Japan | | AstraZeneca | Bronchial Asthma | 05/13 | 05/13 | | |
NCT01961154: Stepping Down of Asthma Medication in Controlled Asthma |
|
|
| Completed | N/A | 56 | Europe | Asthma medication reduction, Seretide, Symbicort | Kuopio University Hospital | Asthma | 07/15 | 07/15 | | |
NCT01711840: Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy |
|
|
| Completed | N/A | 2409 | Japan | | AstraZeneca | Bronchial Asthma | 08/15 | 08/15 | | |
| Completed | N/A | 84 | Europe | Spiromax (budesonide/formoterol), Turbohaler (budesonide/formoterol), Diskus(50mcg salmeterol &250/500 mcg fluticasone propionate) | Consorzio Futuro in Ricerca | Asthma, COPD | 12/17 | 01/18 | | |
